Home > Healthcare > Medical Devices > Diagnostic Devices > Hemodynamic Monitoring Devices Market

Hemodynamic Monitoring Devices Market Share

Report ID: GMI7995
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Hemodynamic Monitoring Devices Market Share

The market is a consolidated, dynamic, and a rapidly evolving sector, characterized by significant technological advancements and competitive activities among leading players. Key market participants, including Edwards Lifesciences Corporation, Koninklijke Philips N.V., GE HealthCare, and Siemens Healthineers AG, are driving innovation through advanced hemodynamic monitoring devices technologies, expanded product offerings, and strategic collaborations. Companies that successfully leverage these opportunities and address market challenges are well-positioned for success in the competitive hemodynamic monitoring devices landscape.

Hemodynamic Monitoring Devices Market Companies

Some of the eminent market participants operating in the hemodynamic monitoring devices industry include:

Abbott Laboratories
Baxter International
Canon Medical Systems Corporation
Deltex Medical Group
Edwards Lifesciences Corporation
GE HealthCare Technologies
Getinge
ICU Medical
Koninklijke Philips N.V.
Masimo Corporation
Nihon Kohden Corporation
OSYPKA MEDICAL
Siemens Healthineers

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global hemodynamic monitoring devices industry was valued at around USD 1.4 billion in 2023 and is estimated to grow at a 6.7% CAGR from 2024 to 2032, driven by the increasing need for cardiovascular system assessment tools.

The disposables segment dominated the market with a revenue of USD 437.9 million in 2023, as single-use items are crucial in minimizing the risk of cross-contamination and hospital-acquired infections (HAIs).

North American market for hemodynamic monitoring devices recorded USD 470.5 million in 2023 and is forecasted to reach USD 888.1 million by 2032, driven by the rising prevalence of chronic diseases.

Key players in the industry include Abbott Laboratories, Baxter International, Canon Medical Systems Corporation, Deltex Medical Group, Edwards Lifesciences Corporation, GE HealthCare Technologies, Getinge, ICU Medical, and Koninklijke Philips N.V.